Mario Balsa, Medical Oncology resident at ICO, shared a post on X:
“New in Frontiers – Oncology by Aakash Desai, Ahmed Ismail and Yanis Boumber.
HER2-Altered NSCLC: From Research to Therapeutic Targets
Love it!! But…can HER2 keep dancing when resistance cuts the music?”
Title: HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalities
Authors: Aakash Desai, Ahmed Ismail and Yanis Boumber
You can read the Full Article on Frontiers – Oncology
More posts featuring NSCLC.
